The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Randomized trials of patients in cardiogenic shock (CS) have been challenging to conduct. The DanGer Shock (Microaxial Flow Pump in Infarct-Related Cardiogenic Shock) trial was an important study in ...
Most of the change in stage of cardiogenic shock (CS) occurred within the first 24 hours of presentation, with little change thereafter, according to a study by the Cardiogenic Shock Working Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results